These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37543582)

  • 1. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
    Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
    Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutations in hairy-cell leukemia.
    Tiacci E; Trifonov V; Schiavoni G; Holmes A; Kern W; Martelli MP; Pucciarini A; Bigerna B; Pacini R; Wells VA; Sportoletti P; Pettirossi V; Mannucci R; Elliott O; Liso A; Ambrosetti A; Pulsoni A; Forconi F; Trentin L; Semenzato G; Inghirami G; Capponi M; Di Raimondo F; Patti C; Arcaini L; Musto P; Pileri S; Haferlach C; Schnittger S; Pizzolo G; Foà R; Farinelli L; Haferlach T; Pasqualucci L; Rabadan R; Falini B
    N Engl J Med; 2011 Jun; 364(24):2305-15. PubMed ID: 21663470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
    Falini B; Martelli MP; Tiacci E
    Blood; 2016 Oct; 128(15):1918-1927. PubMed ID: 27554081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
    Tiacci E; Schiavoni G; Martelli MP; Boveri E; Pacini R; Tabarrini A; Zibellini S; Santi A; Pettirossi V; Fortini E; Ascani S; Arcaini L; Inghirami G; Paulli M; Falini B
    Haematologica; 2013 Apr; 98(4):635-9. PubMed ID: 23349307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.
    Pettirossi V; Santi A; Imperi E; Russo G; Pucciarini A; Bigerna B; Schiavoni G; Fortini E; Spanhol-Rosseto A; Sportoletti P; Mannucci R; Martelli MP; Klein-Hitpass L; Falini B; Tiacci E
    Blood; 2015 Feb; 125(8):1207-16. PubMed ID: 25480661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.
    Itamura H; Ide M; Sato A; Sueoka-Aragane N; Sueoka E; Nishida A; Masunari T; Aoki S; Takizawa J; Suzumiya J; Kimura S
    Int J Hematol; 2018 Oct; 108(4):416-422. PubMed ID: 30043333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of Hairy Cell Leukemia.
    Tiacci E; Pettirossi V; Schiavoni G; Falini B
    J Clin Oncol; 2017 Mar; 35(9):1002-1010. PubMed ID: 28297625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
    Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
    Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia.
    Andrulis M; Penzel R; Weichert W; von Deimling A; Capper D
    Am J Surg Pathol; 2012 Dec; 36(12):1796-800. PubMed ID: 22531170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.
    Arcaini L; Zibellini S; Boveri E; Riboni R; Rattotti S; Varettoni M; Guerrera ML; Lucioni M; Tenore A; Merli M; Rizzi S; Morello L; Cavalloni C; Da Vià MC; Paulli M; Cazzola M
    Blood; 2012 Jan; 119(1):188-91. PubMed ID: 22072557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
    Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
    Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.
    Wang XJ; Kim A; Li S
    Int J Clin Exp Pathol; 2014; 7(7):4323-8. PubMed ID: 25120816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.
    Tiacci E; Schiavoni G; Forconi F; Santi A; Trentin L; Ambrosetti A; Cecchini D; Sozzi E; Francia di Celle P; Di Bello C; Pulsoni A; Foà R; Inghirami G; Falini B
    Blood; 2012 Jan; 119(1):192-5. PubMed ID: 22028477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-canonical
    Langabeer SE
    Oncol Res; 2024; 32(9):1423-1427. PubMed ID: 39220131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
    Turakhia S; Lanigan C; Hamadeh F; Swerdlow SH; Tubbs RR; Cook JR
    Am J Clin Pathol; 2015 Jul; 144(1):87-93. PubMed ID: 26071465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias.
    Tschernitz S; Flossbach L; Bonengel M; Roth S; Rosenwald A; Geissinger E
    Br J Haematol; 2014 May; 165(4):529-33. PubMed ID: 24433452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.
    Zhang R; Wu Y; Wang X; Lu X; Li Y; Li S; Yan X
    Int J Med Sci; 2020; 17(3):325-331. PubMed ID: 32132867
    [No Abstract]   [Full Text] [Related]  

  • 18. BRAF inhibitor therapy in HCL.
    Dietrich S; Zenz T
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):246-52. PubMed ID: 26614903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.
    Ewalt M; Nandula S; Phillips A; Alobeid B; Murty VV; Mansukhani MM; Bhagat G
    Hematol Oncol; 2012 Dec; 30(4):190-3. PubMed ID: 22246856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia.
    Arora N; Nair S; Pai R; Nair S; Ahmed R; Abraham A; Viswabandya A; George B; Balasubramanian P; Srivastava A; Mathews V
    Indian J Pathol Microbiol; 2015; 58(1):62-5. PubMed ID: 25673595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.